Car Seat Foam Could Expose You To Carcinogens, By The Way
It seems like everything causes cancer these days, and now researchers are learning how our cars may expose us all to potentially cancer-causing chemicals. As it turns out, some of …
It seems like everything causes cancer these days, and now researchers are learning how our cars may expose us all to potentially cancer-causing chemicals. As it turns out, some of …
New Delhi: The Centre Tuesday formed a high-level panel to introduce reforms in the pricing framework for drugs and medical devices, ThePrint has learnt. The committee will be chaired by …
Neuralink, Billionaire Elon Musk’s tiny side hustle and dating service, began brain-computer interface implant long-term trials in human subjects late last month, the third such company to do so. There …
As the results for the Oct-Dec quarter are unveiled, insights from management commentaries across various sectors provide valuable indicators of the Indian economy’s health. Businesses serve as the backbone of …
Photo: Slaven Vlasic (Getty Images) Elon Musk announced that Neuralink has implanted a computer chip in the brain of its first human patient. Tesla’s Cybertruck Has Finally Arrived Neuralink implanted …
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has rejected Danish pharma giant Novo Nordisk’s application to import and sell a treatment touted as the world’s first weekly insulin, …
Anshul Saigal, Founder, Saigal Capital, says “one should really focus on bottom-up opportunities, not worry about the market levels, market direction. As long as we have got good companies at …
Even as the raw material cost climbed down from 25% of revenues a year ago to 23% in the September quarter, the other expenses increased from 28% of revenues to …
Abhishek Basumallick, Founder & Chief Equity Advisor, Intelsense Capital, says “right now is a very good time to buy for probably the next two to three years. Right now means …
Mumbai: Concord Biotech’s strong foothold in the niche segment of manufacturing active pharmaceutical ingredients through fermentation along with its capacity expansion and planned launches are seen underpinning strong earnings growth …